The duration and course of opioid therapy in patients with chronic non-malignant pain

Acta Anaesthesiologica Scandinavica

Volumn 60, Issue 1, 2016, Pages 128-137

  Mellbye, A ^a,b   Karlstad, O ^d   Skurtveit, S ^c,d   Borchgrevink, P C ^a,b   Fredheim, O M S ^a,b,e  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^e AKERSHUS UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ALFENTANIL; BENZODIAZEPINE DERIVATIVE; BUPRENORPHINE PLUS NALOXONE; HYPNOTIC AGENT; METHADONE; MORPHINE; OPIATE; REMIFENTANIL; SUFENTANIL; HYPNOTIC SEDATIVE AGENT; NARCOTIC ANALGESIC AGENT; PRESCRIPTION DRUG;

ADULT; ANALGESIA; ARTICLE; CANCER PAIN; CHRONIC PAIN; CONTROLLED STUDY; DATA BASE; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG MEGADOSE; DRUG USE; FEMALE; HUMAN; LONG TERM CARE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; NONMALIGNANT PAIN; NORWAY; PRESCRIPTION; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT OUTCOME; AGED; COHORT ANALYSIS; COMBINATION DRUG THERAPY; DRUG ADMINISTRATION; DRUG UTILIZATION; EPIDEMIOLOGY; FACTUAL DATABASE; MIDDLE AGED; PROSPECTIVE STUDY;

ADULT; AGED; ANALGESICS, OPIOID; BENZODIAZEPINES; CHRONIC PAIN; COHORT STUDIES; DATABASES, FACTUAL; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; DRUG UTILIZATION; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MIDDLE AGED; NORWAY; PRESCRIPTION DRUGS; PROSPECTIVE STUDIES;

EID: 84955211264     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/aas.12594     Document Type: Article

References (36)

1. Eriksen J, Sjogren P, Bruera E, Ekholm O, Rasmussen NK,. Critical issues on opioids in chronic non-cancer pain: an epidemiological study. Pain 2006; 125: 172-9.
2. Sullivan MD, Howe CQ,. Opioid therapy for chronic pain in the US: promises and perils. Pain 2013; 154: S94-100.
3. Freynhagen R, Geisslinger G, Schug SA,. Opioids for chronic non-cancer pain. BMJ 2013; 346: f2937.
4. Chou R, Fanciullo GJ, Fine PG, Adler JA, Ballantyne JC, Davies P, Donovan MI, Fishbain DA, Foley KM, Fudin J, Gilson AM, Kelter A, Mauskop A, O'Connor PG, Passik SD, Pasternak GW, Portenoy RK, Rich BA, Roberts RG, Todd KH, Miaskowski C,. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain 2009; 10: 113-30.
5. Boudreau D, Von Korff M, Rutter CM, Saunders K, Ray GT, Sullivan MD, Campbell CI, Merrill JO, Silverberg MJ, Banta-Green C, Weisner C,. Trends in long-term opioid therapy for chronic non-cancer pain. Pharmacoepidemiol Drug Saf 2009; 18: 1166-75.
6. Fredheim OMS, Skurtveit S, Breivik H, Borchgrevink PC,. Increasing use of opioids from 2004 to 2007-Pharmacoepidemiological data from a complete national prescription database in Norway. Eur J Pain 2010; 14: 289-94.
7. Garcia del Pozo J, Carvajal A, Viloria JM, Velasco A, Garcia del Pozo V,. Trends in the consumption of opioid analgesics in Spain. Higher increases as fentanyl replaces morphine. Eur J Clin Pharmacol 2008; 64: 411-5.
8. Eriksen J, Jensen MK, Sjogren P, Ekholm O, Rasmussen NK,. Epidemiology of chronic non-malignant pain in Denmark. Pain 2003; 106: 221-8.
9. Ruscitto A, Smith BH, Guthrie B,. Changes in opioid and other analgesic use 1995-2010: repeated cross-sectional analysis of dispensed prescribing for a large geographical population in Scotland. Eur J Pain 2015; 19: 56.
10. The British Pain Society. Opioids for persistent pain: good practice, 2010. Available at: http://www.britishpainsociety.org/book-opioid-main.pdf (accessed 04 April 2015).
11. National Pain Centre. Canadian guideline for safe and effective use of opioids for chronic non-cancer pain. McMaster University, 2010. Available at: http://nationalpaincentre.mcmaster.ca/opioid/ (accessed 04 April 2015).
12. The Norwegian Directorate of Health. National Guidelines: The use of opioids in the treatment of long-lasting non-malignant pain, 2014. Available at: https://sites.helsedirektoratet.no/sites/bruk-av-opioider/Sider/default.aspx (accessed 04 April 2015).
13. Mellbye A, Svendsen K, Borchgrevink PC, Skurtveit S, Fredheim OMS,. Concomitant medication among persistent opioid users with chronic non-malignant pain. Acta Anaesthesiol Scand 2012; 56: 1267-76.
14. Skurtveit S, Furu K, Borchgrevink P, Handal M, Fredheim OMS,. To what extent does a cohort of new users of weak opioids develop persistent or probable problematic opioid use? Pain 2011; 152: 1555-61.
15. Fredheim OMS, Borchgrevink PC, Mahic M, Skurtveit S,. A pharmacoepidemiological cohort study of subjects starting strong opioids for nonmalignant pain: a study from the Norwegian Prescription Database. Pain 2013; 154: 2487-93.
16. Fredheim OMS, Mahic M, Skurtveit S, Dale O, Romundstad P, Borchgrevink PC,. Chronic pain and use of opioids: a population based pharmacoepidemiological study from the Norwegian prescription database and the Nord-Trøndelag health study. Pain 2014; 155: 1213-21.
17. Braden JB, Russo J, Fan M-Y, Edlund MJ, Martin BC, DeVries A, Sullivan MD,. Emergency department visits among recipients of chronic opioid therapy. Arch Intern Med 2010; 170: 1425-32.
18. Fleming MF, Balousek SL, Klessig CL, Mundt MP, Brown DD,. Substance use disorders in a primary care sample receiving daily opioid therapy. J Pain 2007; 8: 573-82.
19. Højsted J, Ekholm O, Kurita GP, Juel K, Sjøgren P,. Addictive behaviors related to opioid use for chronic pain: a population-based study. Pain 2013; 154: 2677-83.
20. Martin BC, Fan M-Y, Edlund MJ, Devries A, Braden JB, Sullivan MD,. Long-term chronic opioid therapy discontinuation rates from the TROUP study. J Gen Intern Med 2011; 26: 1450-7.
21. Nielsen S, Lintzeris N, Bruno R, Campbell G, Larance B, Hall W, Hoban B, Cohen ML, Degenhardt L,. Benzodiazepine use among chronic pain patients prescribed opioids: associations with pain, physical and mental health, and health service utilization. Pain Med 2015; 16: 356-66.
22. Saunders KW, Von Korff M, Campbell CI, Banta-Green CJ, Sullivan MD, Merrill JO, Weisner C,. Concurrent use of alcohol and sedatives among persons prescribed chronic opioid therapy: prevalence and risk factors. J Pain 2012; 13: 266-75.
23. Maier C, Schaub C, Willweber-Strumpf A, Zenz M,. [Long-term efficiency of opioid medication in patients with chronic non-cancer-associated pain. Results of a survey 5 years after onset of medical treatment]. Schmerz 2005; 19: 410-7.
24. Kalso E, Edwards JE, Moore RA, McQuay HJ,. Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain 2004; 112: 372-80.
25. Noble M, Treadwell JR, Tregear SJ, Coates VH, Wiffen PJ, Akafomo C, Schoelles KM,. Long-term opioid management for chronic noncancer pain. Cochrane Database Syst Rev 2010; CD006605. doi: 10.1002/14651858.CD006605.pub2.
26. Furu K, Wettermark B, Andersen M, Martikainen JE, Almarsdottir AB, Sørensen HT,. The Nordic countries as a cohort for pharmacoepidemiological research. Basic Clin Pharmacol Toxicol 2010; 106: 86-94.
27. Svendsen K, Borchgrevink PC, Fredheim O, Hamunen K, Mellbye A, Dale O,. Choosing the unit of measurement counts: the use of oral morphine equivalents in studies of opioid consumption is a useful addition to defined daily doses. Palliat Med 2011; 25: 725-32.
28. Svendsen K, Skurtveit S, Romundstad P, Borchgrevink PC, Fredheim OMS,. Differential patterns of opioid use: defining persistent opioid use in a prescription database. Eur J Pain 2012; 16: 359-69.
29. Jensen MK, Thomsen AB, Hojsted J,. 10-year follow-up of chronic non-malignant pain patients: opioid use, health related quality of life and health care utilization. Eur J Pain 2006; 10: 423-33.
30. Edlund MJ, Martin BC, Fan M-Y, Devries A, Braden JB, Sullivan MD,. Risks for opioid abuse and dependence among recipients of chronic opioid therapy: results from the TROUP study. Drug Alcohol Depend 2010; 112: 90-8.
31. Dunn KM, Saunders KW, Rutter CM, Banta-Green CJ, Merrill JO, Sullivan MD, Weisner CM, Silverberg MJ, Campbell CI, Psaty BM, Von Korff M,. Opioid prescriptions for chronic pain and overdose: a cohort study. Ann Intern Med 2010; 152: 85-92.
32. Chou R, Turner JA, Devine EB, Hansen RN, Sullivan SD, Blazina I, Dana T, Bougatsos C, Deyo RA,. The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a national institutes of health pathways to prevention workshop. Ann Intern Med 2015; 162: 276-86.
33. Braden JB, Sullivan MD, Ray GT, Saunders K, Merrill J, Silverberg MJ, Rutter CM, Weisner C, Banta-Green C, Campbell C, Von Korff M,. Trends in long-term opioid therapy for noncancer pain among persons with a history of depression. Gen Hosp Psychiatry 2009; 31: 564-70.
34. Edlund MJ, Martin BC, Devries A, Fan M, Braden JB, Sullivan MD,. Trends in use of opioids for chronic noncancer pain among individuals with mental health and substance use disorders: the TROUP study. Clin J Pain 2010; 26: 1-8.
35. Sullivan MD, Edlund MJ, Steffick D, Unützer J,. Regular use of prescribed opioids: association with common psychiatric disorders. Pain 2005; 119: 95-103.
36. The Norwegian Directorate of Health. National Guidelines: Prescribing and safety of addictive drugs, 2014. Available at: https://sites.helsedirektoratet.no/sites/vanedannende-legemidler/Sider/default.aspx (accessed 04 April 2015).